Viewing Study NCT04851834


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-27 @ 10:52 AM
Study NCT ID: NCT04851834
Status: TERMINATED
Last Update Posted: 2022-12-20
First Post: 2021-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
Sponsor: Xennials Therapeutics Australia Pty Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module